Monday, April 20, 2015

Daiichi Sankyo sells stake in Sun Pharma

Sun Pharma shares crashed 11% early in trade today following the news that Daiichi Sankyo had sold its stake between 930-968 Rs per share.

Daiichi Sankyo sold 8.9% stake.

It had obtained the stake following the merger of Ranbaxy with Sun Pharma.

The merger with Ranbaxy has fortified Sun Pharma's position as the world's fifth largest specialty generic pharma firm.

The merger with Ranbaxy has fortified Sun Pharma's position as the world's fifth largest specialty generic pharma firm and the top-ranking domestic one with a significant lead in the market share.

Read more at: http://www.moneycontrol.com/news/buzzing-stocks/sun-pharma-plunges-11-as-daiichi-sankyo-offloads-stake_1363247.html?utm_source=ref_article
The merger with Ranbaxy has fortified Sun Pharma's position as the world's fifth largest specialty generic pharma firm and the top-ranking domestic one with a significant lead in the market share.

Read more at: http://www.moneycontrol.com/news/buzzing-stocks/sun-pharma-plunges-11-as-daiichi-sankyo-offloads-stake_1363247.html?utm_source=ref_article
The merger with Ranbaxy has fortified Sun Pharma's position as the world's fifth largest specialty generic pharma firm and the top-ranking domestic one with a significant lead in the market share.

Read more at: http://www.moneycontrol.com/news/buzzing-stocks/sun-pharma-plunges-11-as-daiichi-sankyo-offloads-stake_1363247.html?utm_source=ref_article
The merger with Ranbaxy has fortified Sun Pharma's position as the world's fifth largest specialty generic pharma firm and the top-ranking domestic one with a significant lead in the market share.

Read more at: http://www.moneycontrol.com/news/buzzing-stocks/sun-pharma-plunges-11-as-daiichi-sankyo-offloads-stake_1363247.html?utm_source=ref_article

No comments:

Post a Comment